PNB-001 (GPP-BALACOVIN)
-
PNB Vesper to conduct Phase III clinical trials on covid drug, gets DCGI nod
PNB 001/ GPP-BALACOVIN is proving to be a breakthrough in COVID-19 treatment Kerala-based PNB Vesper has received DCGI permission to…
Read More »